Author:
Lee C P,Payne G S,Oregioni A,Ruddle R,Tan S,Raynaud F I,Eaton D,Campbell M J,Cross K,Halbert G,Tracy M,McNamara J,Seddon B,Leach M O,Workman P,Judson I
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Aboagye EO, Graham MA, Lewis AD, Workman P, Kelson AB, Tracy M (1995a) Development and validation of a solid-phase extraction and high-performance liquid chromatographic assay for a novel fluorinated 2-nitroimidazole hypoxia probe (SR-4554) in Balb/c mouse plasma. J Chromatogr B Biomed Appl 672: 125–132
2. Aboagye EO, Kelson AB, Tracy M, Workman P (1998a) Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography. Anticancer Drug Des 13: 703–730
3. Aboagye EO, Lewis AD, Graham MA, Tracy M, Kelson AB, Ryan KJ, Workman P (1996) The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554. Anticancer Drug Des 11: 231–242
4. Aboagye EO, Lewis AD, Johnson A, Workman P, Tracy M, Huxham IM (1995b) The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localization in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis. Br J Cancer 72: 312–318
5. Aboagye EO, Lewis AD, Tracy M, Workman P (1997a) Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554). Biochem Pharmacol 54: 1217–1224
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献